CN106434748A - Development and applications of heat shock induced Cas9 enzyme transgene danio rerio - Google Patents
Development and applications of heat shock induced Cas9 enzyme transgene danio rerio Download PDFInfo
- Publication number
- CN106434748A CN106434748A CN201610614071.XA CN201610614071A CN106434748A CN 106434748 A CN106434748 A CN 106434748A CN 201610614071 A CN201610614071 A CN 201610614071A CN 106434748 A CN106434748 A CN 106434748A
- Authority
- CN
- China
- Prior art keywords
- cas9
- cas9 enzyme
- gene
- zebrafish
- enzymes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091033409 CRISPR Proteins 0.000 title claims abstract description 92
- 241000252212 Danio rerio Species 0.000 title claims abstract description 57
- 230000035939 shock Effects 0.000 title abstract description 8
- 238000011161 development Methods 0.000 title abstract description 3
- 108700019146 Transgenes Proteins 0.000 title description 2
- 230000014509 gene expression Effects 0.000 claims abstract description 37
- 241000251468 Actinopterygii Species 0.000 claims abstract description 34
- 230000009261 transgenic effect Effects 0.000 claims abstract description 31
- 101710163595 Chaperone protein DnaK Proteins 0.000 claims abstract description 7
- 101710178376 Heat shock 70 kDa protein Proteins 0.000 claims abstract description 7
- 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 claims abstract description 7
- 230000001939 inductive effect Effects 0.000 claims abstract description 6
- 238000011160 research Methods 0.000 claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 26
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 238000002347 injection Methods 0.000 claims description 12
- 239000007924 injection Substances 0.000 claims description 12
- 238000012216 screening Methods 0.000 claims description 9
- 239000003550 marker Substances 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 238000009395 breeding Methods 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 4
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 3
- 230000004720 fertilization Effects 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 210000004602 germ cell Anatomy 0.000 claims 4
- 241000448255 Congiopodus peruvianus Species 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 210000004681 ovum Anatomy 0.000 claims 1
- 235000013601 eggs Nutrition 0.000 abstract description 31
- 239000013604 expression vector Substances 0.000 abstract description 22
- 101150110867 MC4R gene Proteins 0.000 abstract description 11
- 238000012986 modification Methods 0.000 abstract description 7
- 230000004048 modification Effects 0.000 abstract description 7
- 108020004999 messenger RNA Proteins 0.000 abstract description 5
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 abstract description 4
- 238000003209 gene knockout Methods 0.000 abstract description 4
- 238000010362 genome editing Methods 0.000 abstract description 3
- 238000003198 gene knock in Methods 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 108020005004 Guide RNA Proteins 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 108091026890 Coding region Proteins 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000000520 microinjection Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000008685 targeting Effects 0.000 description 5
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 4
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 241000238582 Artemia Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 210000002969 egg yolk Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 108010077544 Chromatin Proteins 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
- 238000010459 TALEN Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000003483 chromatin Anatomy 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010363 gene targeting Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000017448 oviposition Effects 0.000 description 2
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000252210 Cyprinidae Species 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 101100129529 Danio rerio mc4r gene Proteins 0.000 description 1
- 241000283070 Equus zebra Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000978418 Homo sapiens Melanocortin receptor 4 Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102100023724 Melanocortin receptor 4 Human genes 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000019439 energy homeostasis Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000221 frame shift mutation induction Toxicity 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108010008359 protein kinase C lambda Proteins 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 108700024526 zebrafish sox32 Proteins 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/40—Fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/60—Vectors containing traps for, e.g. exons, promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明属于生物技术领域,具体涉及一种热激诱导型Cas9酶转基因斑马鱼的研制及应用。本发明首先提供了一种Cas9酶表达载体,所述载体利用热激诱导型启动子HSP70来驱动下游Cas9基因表达。采用所述Cas9酶表达载体和Tol2 mRNA共同注射入野生型斑马鱼单细胞受精卵,选育得到热激诱导型Cas9酶转基因斑马鱼,成功实现了在斑马鱼中进行CRISPR‑Cas9系统的基因编辑研究,并首次实现了MC4R基因在此转基因斑马鱼中的敲除。所述Cas9酶表达载体同样适用于其他鱼类的热激诱导型基因敲除、基因敲入、基因表达修饰等应用。The invention belongs to the field of biotechnology, and in particular relates to the development and application of a heat-shock-inducible Cas9 enzyme transgenic zebrafish. The present invention firstly provides a Cas9 enzyme expression vector, which uses a heat shock inducible promoter HSP70 to drive downstream Cas9 gene expression. The Cas9 enzyme expression vector and Tol2 mRNA were co-injected into wild-type zebrafish single-cell fertilized eggs, and the heat-shock-inducible Cas9 enzyme transgenic zebrafish was bred, and the gene editing of the CRISPR-Cas9 system in zebrafish was successfully realized. Research, and achieved the knockout of MC4R gene in this transgenic zebrafish for the first time. The Cas9 enzyme expression vector is also suitable for applications such as heat-shock-inducible gene knockout, gene knock-in, and gene expression modification of other fish.
Description
技术领域technical field
本发明属于生物技术领域,具体涉及一种热激诱导型Cas9酶转基因斑马鱼的研制及应用。The invention belongs to the field of biotechnology, and in particular relates to the development and application of a heat-shock-inducible Cas9 enzyme transgenic zebrafish.
背景技术Background technique
斑马鱼(Danio rerio)是属于辐鳍亚纲(Actinopterygii)鲤科(Cyprinidae)短担尼鱼属(Danio)的一种硬骨鱼,因其体侧具有像斑马一样纵向的暗蓝与银色相间的条纹而得名。斑马鱼与人类基因有着87%的高度同源性,这意味着以斑马鱼为实验动物,得到的结果大多数情况下可以适用于人体,因此其作为模式生物的优势很突出。其幼鱼具有繁殖快,卵及幼鱼全身透明的特点,常被用于水环境污染物的监测,相关疾病模型的制作等等。其中转基因技术的成熟也给斑马鱼的应用带来的更大的前景。转基因斑马鱼的制备通常包括以下几个步骤:首先构建好转基因重组表达载体,利用经典的显微注射技术将带有目的基因或荧光基因的重组表达载体导入斑马鱼单细胞受精卵中,使外源目的基因或荧光基因能够整合到斑马鱼胚胎染色体上,并使目的基因或荧光标记基因表达,通过PCR或者荧光显微镜来检测外源基因是否整合和表达成功,从而筛选和鉴定转基因后代或转基因的嵌合体。The zebrafish (Danio rerio) is a bony fish belonging to the genus Danio of the family Cyprinidae in the subclass Actinopterygii, because it has longitudinal dark blue and silver stripes like a zebra on the side of its body. named after the stripes. Zebrafish has a high degree of homology of 87% with human genes, which means that the results obtained using zebrafish as experimental animals can be applied to humans in most cases, so its advantages as a model organism are very prominent. Its juveniles have the characteristics of rapid reproduction, transparent eggs and juveniles, and are often used for monitoring water environment pollutants, making related disease models, and so on. Among them, the maturity of transgenic technology also brings greater prospects for the application of zebrafish. The preparation of transgenic zebrafish usually includes the following steps: First, construct the recombinant expression vector of the transgene, and then introduce the recombinant expression vector with the target gene or fluorescent gene into zebrafish single-cell fertilized eggs by using classical microinjection technology, so that the outer The source target gene or fluorescent gene can be integrated into the chromosome of the zebrafish embryo, and the target gene or fluorescent marker gene can be expressed, and the integration and expression of the foreign gene can be detected by PCR or fluorescent microscope, so as to screen and identify transgenic offspring or transgenic Chimera.
CRISPR-Cas9系统成功被改造为第三代人工核酸内切酶,与锌指核酸内切酶(ZFN)和类转录激活因子效应物核酸酶(TALEN)一样可用于各种复杂基因组的编辑。其主要功能部件包括识别靶位点的gRNA和Cas9蛋白,gRNA负责识别靶位点,Cas9蛋白行使剪切功能,再利用机体自身的非同源末端修复(NHEJ),在修复的过程中给基因组引入突变。目前该技术已成功应用于人类细胞,斑马鱼和小鼠以及细菌的基因组精确修饰,修饰类型包括插入缺失突变、基因定点敲入、大片段的缺失。由于其突变效率高、制作简单及成本低的特点,被认为是一种具有广阔应用前景的基因组定点改造分子工具。MC4R属于G-蛋白偶联受体的家族,是下丘脑腹内侧核分泌的一类肽类物质,在调节能量动态平衡和肥胖症发生上具有重要作用。通过十几年的研究,MC4R基因在哺乳动物中的功能研究已经比较透彻。然而,因为鱼类中缺乏有效的基因编辑手段,鱼类的MC4R基因功能的研究才刚刚起步。The CRISPR-Cas9 system has been successfully transformed into a third-generation artificial endonuclease, which, like zinc finger endonuclease (ZFN) and transcription activator-like effector nuclease (TALEN), can be used for editing various complex genomes. Its main functional components include gRNA and Cas9 protein that recognize the target site. The gRNA is responsible for recognizing the target site, and the Cas9 protein performs the cutting function. Introduce mutations. At present, this technology has been successfully applied to the precise genome modification of human cells, zebrafish, mice, and bacteria. The types of modification include insertion-deletion mutations, gene-directed knock-in, and large-segment deletions. Due to its high mutation efficiency, simple production and low cost, it is considered to be a molecular tool for targeted genome modification with broad application prospects. MC4R belongs to the family of G-protein-coupled receptors and is a kind of peptide substance secreted by the ventromedial nucleus of the hypothalamus. It plays an important role in regulating energy homeostasis and obesity. Through more than ten years of research, the functional research of MC4R gene in mammals has been relatively thorough. However, due to the lack of effective gene editing methods in fish, the research on the function of MC4R gene in fish has just started.
发明内容Contents of the invention
为了克服现有技术中所存在的问题,本发明的目的在于提供一种热激诱导型Cas9酶转基因斑马鱼的制作方法及应用。In order to overcome the problems existing in the prior art, the object of the present invention is to provide a production method and application of heat shock-inducible Cas9 enzyme transgenic zebrafish.
为了实现上述目的以及其他相关目的,本发明采用如下技术方案:In order to achieve the above object and other related objects, the present invention adopts the following technical solutions:
本发明的第一方面,提供一种Cas9酶表达载体,包括:Cas9酶表达元件以及位于所述Cas9酶表达元件两端的转座子Tol2,所述Cas9酶表达元件包括热激诱导型启动子HSP70和Cas9酶基因编码序列。The first aspect of the present invention provides a Cas9 enzyme expression vector, comprising: a Cas9 enzyme expression element and a transposon Tol2 located at both ends of the Cas9 enzyme expression element, and the Cas9 enzyme expression element includes a heat shock inducible promoter HSP70 and Cas9 enzyme gene coding sequence.
优选地,所述热激诱导型启动子HSP70含有如SEQ ID NO.7所示的序列。Preferably, the heat shock-inducible promoter HSP70 contains the sequence shown in SEQ ID NO.7.
优选地,所述Cas9酶基因编码序列含有如SEQ ID NO.8所示的序列。Preferably, the Cas9 enzyme gene coding sequence contains the sequence shown in SEQ ID NO.8.
优选地,位于所述Cas9酶表达元件两端的转座子Tol2包括位于所述Cas9酶表达元件5’端的转座子Tol2和位于所述Cas9酶表达元件3’端的转座子Tol2。Preferably, the transposon Tol2 positioned at both ends of the Cas9 enzyme expression element comprises the transposon Tol2 positioned at the 5' end of the Cas9 enzyme expression element and the transposon Tol2 positioned at the 3' end of the Cas9 enzyme expression element.
优选地,位于所述Cas9酶表达元件5’端的转座子Tol2含有如SEQ ID NO.9所示的序列。Preferably, the transposon Tol2 located at the 5' end of the Cas9 enzyme expression element contains the sequence shown in SEQ ID NO.9.
优选地,位于所述Cas9酶表达元件3’端的转座子Tol2含有如SEQ ID NO.10所示的序列。Preferably, the transposon Tol2 located at the 3' end of the Cas9 enzyme expression element contains the sequence shown in SEQ ID NO.10.
优选地,所述Cas9酶表达元件还包括荧光标记蛋白序列。Preferably, the Cas9 enzyme expression element also includes a fluorescent marker protein sequence.
优选地,所述荧光标记蛋白序列通过2A序列与Cas9酶基因编码序列连接。Preferably, the fluorescent marker protein sequence is connected to the coding sequence of the Cas9 enzyme gene through a 2A sequence.
进一步优选地,所述2A序列含有如SEQ ID NO.11所示的序列。Further preferably, the 2A sequence contains the sequence shown in SEQ ID NO.11.
优选地,所述荧光标记蛋白为绿色荧光蛋白eGFP。Preferably, the fluorescent marker protein is green fluorescent protein eGFP.
优选地,所述Cas9酶表达载体含有如SEQ ID NO.12所示的序列。Preferably, the Cas9 enzyme expression vector contains the sequence shown in SEQ ID NO.12.
本发明的第二方面,提供前述Cas9酶表达载体在培育Cas9酶转基因动物中的用途。The second aspect of the present invention provides the use of the aforementioned Cas9 enzyme expression vector in cultivating Cas9 enzyme transgenic animals.
本发明的第三方面,提供一种Cas9酶转基因斑马鱼培养方法,包括:将前述Cas9酶表达载体和Tol2mRNA共同注射入野生型斑马鱼单细胞受精卵,选育得到Cas9酶转基因斑马鱼。A third aspect of the present invention provides a Cas9 enzyme transgenic zebrafish culture method, comprising: co-injecting the aforementioned Cas9 enzyme expression vector and Tol2 mRNA into wild-type zebrafish single-cell fertilized eggs, and breeding Cas9 enzyme transgenic zebrafish.
优选地,所述Tol2mRNA含有如SEQ ID NO.13所示的序列。Preferably, the Tol2 mRNA contains the sequence shown in SEQ ID NO.13.
优选地,所述注射采用显微注射法。Preferably, the injection is by microinjection.
优选地,所述选育方法包括:对注射后的受精卵进行热激诱导。Preferably, the breeding method includes: conducting heat shock induction on the injected fertilized eggs.
进一步优选地,所述选育方法具体包括:注射后的受精卵于28℃条件下培育24h,然后在37℃条件下孵育1h,筛选带有荧光标记的鱼卵孵育培养至成鱼。Further preferably, the breeding method specifically comprises: incubating the injected fertilized eggs at 28°C for 24 hours, then incubating at 37°C for 1 hour, screening fish eggs with fluorescent markers, and incubating them until they become adult fish.
优选地,所述选育方法还包括纯系Cas9酶转基因斑马鱼的筛选,Preferably, the breeding method also includes the screening of pure line Cas9 enzyme transgenic zebrafish,
首先选择受精卵中表达荧光的嵌合体P0与野生型斑马鱼进行杂交产生杂合体F1代,筛选后代中发荧光的个体;将所述F1代中发荧光的单个个体和野生型进行测交得到杂合体F2代,筛选后代中发荧光个体;将杂合体F2代中发荧光的雌鱼和雄鱼自交,得到F3代;将所得F3代单个个体继续与野生型测交并统计F4鱼卵孵育后发荧光情况;若F4鱼卵全部为发荧光,则确定其亲本F3为纯系Cas9酶转基因斑马鱼。Firstly, the chimera P0 expressing fluorescence in fertilized eggs is selected to cross with wild-type zebrafish to generate hybrid F1 generation, and the fluorescent individuals in the offspring are screened; the single fluorescent individual in the F1 generation is tested crossed with the wild type to obtain For the heterozygous F2 generation, screen the fluorescent individuals in the progeny; self-cross the fluorescent female and male fish in the heterozygous F2 generation to obtain the F3 generation; continue to testcross the obtained F3 generation with the wild type and count the hatching of F4 fish eggs Fluorescence status; if all F4 fish eggs are fluorescent, it is determined that the parental F3 is a pure Cas9 enzyme transgenic zebrafish.
本发明的第四方面,提供一种由前述方法获得的Cas9酶转基因斑马鱼。The fourth aspect of the present invention provides a Cas9 enzyme transgenic zebrafish obtained by the aforementioned method.
本发明的第五方面,提供了所述Cas9酶转基因斑马鱼用于鱼类基因功能的研究中的用途。The fifth aspect of the present invention provides the use of the Cas9 enzyme transgenic zebrafish in the study of fish gene function.
所述鱼类基因包括但不限于MC4R基因。The fish gene includes but not limited to MC4R gene.
本发明的第六方面,提供了一种研究鱼类基因功能的方法,包括:将针对鱼类基因的sgRNA注射到纯系Cas9酶转基因斑马鱼的单细胞受精卵中,以敲除鱼类基因。The sixth aspect of the present invention provides a method for studying fish gene functions, comprising: injecting sgRNA targeting fish genes into single-cell fertilized eggs of pure Cas9 enzyme transgenic zebrafish to knock out fish genes .
本发明的第七方面,提供一种CRISPR-Cas9基因敲除试剂盒,所述试剂盒包括:前述Cas9酶表达载体和sgRNA。The seventh aspect of the present invention provides a CRISPR-Cas9 gene knockout kit, said kit comprising: the aforementioned Cas9 enzyme expression vector and sgRNA.
与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明首先构建了一种Cas9酶表达载体,所述载体利用热激诱导型启动子HSP70来驱动下游Cas9基因表达。采用所述Cas9酶表达载体和Tol2mRNA共同注射入野生型斑马鱼单细胞受精卵,选育得到热激诱导型Cas9酶转基因斑马鱼,成功实现了在斑马鱼中进行CRISPR-Cas9系统的基因编辑研究,并首次实现了MC4R基因在此转基因斑马鱼中的敲除。所述Cas9酶表达载体同样适用于其他鱼类的热激诱导型基因敲除、基因敲入、基因表达修饰等应用。The present invention first constructs a Cas9 enzyme expression vector, which uses the heat shock inducible promoter HSP70 to drive downstream Cas9 gene expression. The Cas9 enzyme expression vector and Tol2 mRNA were co-injected into wild-type zebrafish single-cell fertilized eggs, and the heat-shock-inducible Cas9 enzyme transgenic zebrafish was bred, and the gene editing research of the CRISPR-Cas9 system in zebrafish was successfully realized. , and achieved the knockout of MC4R gene in this transgenic zebrafish for the first time. The Cas9 enzyme expression vector is also suitable for applications such as heat-shock-inducible gene knockout, gene knock-in, and gene expression modification of other fish.
附图说明Description of drawings
图1是本发明的Cas9表达载体pTol2-HSP70-Cas9-2A-eGFP图谱。Fig. 1 is the map of Cas9 expression vector pTol2-HSP70-Cas9-2A-eGFP of the present invention.
图2是质粒pTol2-LoxP-CMV-eCFP图谱。Figure 2 is a map of plasmid pTol2-LoxP-CMV-eCFP.
图3是质粒pISceI-HSP70-Cas9-2A-eGFP图谱。Figure 3 is a map of plasmid pISceI-HSP70-Cas9-2A-eGFP.
图4是MC4R基因插入缺失测序图,图4中所涉及各序列分别如SEQ ID NO.14~17所示。Fig. 4 is a sequence diagram of the insertion and deletion of MC4R gene, and the sequences involved in Fig. 4 are respectively shown in SEQ ID NO.14-17.
图5是MC4R基因T7E1检测结果电泳图。Fig. 5 is an electrophoresis diagram of the detection result of MC4R gene T7E1.
具体实施方式detailed description
在进一步描述本发明具体实施方式之前,应理解,本发明的保护范围不局限于下述特定的具体实施方案;还应当理解,本发明实施例中使用的术语是为了描述特定的具体实施方案,而不是为了限制本发明的保护范围。下列实施例中未注明具体条件的试验方法,通常按照常规条件,或者按照各制造商所建议的条件。Before further describing the specific embodiments of the present invention, it should be understood that the protection scope of the present invention is not limited to the following specific specific embodiments; it should also be understood that the terms used in the examples of the present invention are to describe specific specific embodiments, It is not intended to limit the protection scope of the present invention. The test methods for which specific conditions are not indicated in the following examples are usually in accordance with conventional conditions, or in accordance with the conditions suggested by each manufacturer.
当实施例给出数值范围时,应理解,除非本发明另有说明,每个数值范围的两个端点以及两个端点之间任何一个数值均可选用。除非另外定义,本发明中使用的所有技术和科学术语与本技术领域技术人员通常理解的意义相同。除实施例中使用的具体方法、设备、材料外,根据本技术领域的技术人员对现有技术的掌握及本发明的记载,还可以使用与本发明实施例中所述的方法、设备、材料相似或等同的现有技术的任何方法、设备和材料来实现本发明。When the examples give numerical ranges, it should be understood that, unless otherwise stated in the present invention, the two endpoints of each numerical range and any value between the two endpoints can be selected. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. In addition to the specific methods, equipment, and materials used in the embodiments, according to those skilled in the art's grasp of the prior art and the description of the present invention, the methods, equipment, and materials described in the embodiments of the present invention can also be used Any methods, apparatus and materials of the prior art similar or equivalent to the practice of the present invention.
除非另外说明,本发明中所公开的实验方法、检测方法、制备方法均采用本技术领域常规的分子生物学、生物化学、染色质结构和分析、分析化学、细胞培养、重组DNA技术及相关领域的常规技术。这些技术在现有文献中已有完善说明,具体可参见Sambrook等MOLECULAR CLONING:A LABORATORY MANUAL,Second edition,Cold Spring HarborLaboratory Press,1989and Third edition,2001;Ausubel等,CURRENT PROTOCOLS INMOLECULAR BIOLOGY,John Wiley&Sons,New York,1987and periodic updates;theseries METHODS IN ENZYMOLOGY,Academic Press,San Diego;Wolffe,CHROMATINSTRUCTURE AND FUNCTION,Third edition,Academic Press,San Diego,1998;METHODS INENZYMOLOGY,Vol.304,Chromatin(P.M.Wassarman and A.P.Wolffe,eds.),AcademicPress,San Diego,1999;和METHODS IN MOLECULAR BIOLOGY,Vol.119,ChromatinProtocols(P.B.Becker,ed.)Humana Press,Totowa,1999等。Unless otherwise stated, the experimental methods, detection methods, and preparation methods disclosed in the present invention all adopt conventional molecular biology, biochemistry, chromatin structure and analysis, analytical chemistry, cell culture, recombinant DNA technology and related fields in the technical field conventional technology. These techniques have been fully described in the existing literature, specifically MOLECULAR CLONING such as Sambrook: A LABORATORY MANUAL, Second edition, Cold Spring Harbor Laboratory Press, 1989 and Third edition, 2001; Ausubel et al., CURRENT PROTOCOLS INMOLECULAR BIOLOGY, John Wiley & Sons, New York, 1987 and periodic updates; theseseries METHODS IN ENZYMOLOGY, Academic Press, San Diego; Wolffe, CHROMATINSTRUCTURE AND FUNCTION, Third edition, Academic Press, San Diego, 1998; METHODS INENZYMOLOGY, Vol. .), Academic Press, San Diego, 1999; and METHODS IN MOLECULAR BIOLOGY, Vol.119, Chromatin Protocols (P.B.Becker, ed.) Humana Press, Totowa, 1999, etc.
实施例1获得Cas9酶表达载体pTol2-HSP70-Cas9-2A-eGFPExample 1 Obtaining the Cas9 enzyme expression vector pTol2-HSP70-Cas9-2A-eGFP
利用BamHI与SalI双酶切质粒载体pTol2-CMV-eGFP(如图2所示),酶切体系:10xGreen Buffer 5ul、质粒载体pTol2-CMV-eGFP 8.8ul(0.284ug/ul)、BamHI 2.5ul、SalI2.5ul、加水补足50ul。通过琼脂糖凝胶电泳回收7993bp的片段,得到骨架片段pTol2。Use BamHI and SalI to double digest the plasmid vector pTol2-CMV-eGFP (as shown in Figure 2). SalI2.5ul, add water to make up 50ul. The 7993bp fragment was recovered by agarose gel electrophoresis to obtain the backbone fragment pTol2.
通过BamHI与SalI双酶切质粒载体pISceI-HSP70-Cas9-2A-eGFP(如图3所示),酶切体系:10x Green Buffer 5ul、质粒载体pISceI-HSP70-Cas9-2A-eGFP 7.7ul(0.321ug/ul)、BamHI2.5ul、SalI 2.5ul、加水补足50ul。酶切完成后,将酶切产物进行琼脂糖凝胶电泳回收6969bp片段,得到插入片段HSP70-Cas9-2A-eGFP。The plasmid vector pISceI-HSP70-Cas9-2A-eGFP was double digested with BamHI and SalI (as shown in Figure 3). ug/ul), BamHI 2.5ul, SalI 2.5ul, add water to make up 50ul. After the digestion was completed, the 6969bp fragment was recovered by agarose gel electrophoresis to obtain the insert fragment HSP70-Cas9-2A-eGFP.
将骨架片段pTol2和插入片段HSP70-Cas9-2A-eGFP两片段进行连接,连接反应体系:HSP70-Cas9-2A-eGFP 3ul、pTol2 2ul、10xBuffer 2ul、T4连接酶0.2ul、灭菌水12.8ul。用T4DNA连接酶16℃连接过夜。The backbone fragment pTol2 and the insert fragment HSP70-Cas9-2A-eGFP were ligated. The ligation reaction system: HSP70-Cas9-2A-eGFP 3ul, pTol2 2ul, 10xBuffer 2ul, T4 ligase 0.2ul, sterile water 12.8ul. T4 DNA ligase was used to ligate overnight at 16°C.
取连接产物10ul转化90ul大肠杆菌感受态细胞DH5α,用移液器轻轻吸打混匀,冰上孵育30min后,42℃热击90s,立即置于冰上2min,加入37℃LB培养基900ul,于37℃180rpm摇床活化1h,活化菌液5000rpm离心3min富集,吸掉900ul上清液,100ul菌液混匀后涂于氨苄抗性培养皿上,于37℃温箱中倒置培养过夜。随机挑选10个单菌落利用PCR方法进行检测,将阳性克隆扩大培养于6ml LB液体培养基,37℃250rpm培养过夜,收集菌液并提取质粒。将得到质粒测序验证,测序结果与预期一致,得到Cas9酶表达载体pTol2-HSP70-Cas9-2A-eGFP。Take 10ul of the ligation product and transform into 90ul Escherichia coli competent cells DH5α, gently pipette and mix well, incubate on ice for 30min, heat shock at 42°C for 90s, immediately place on ice for 2min, add 900ul of LB medium at 37°C , activated on a shaker at 180rpm at 37°C for 1h, centrifuged at 5000rpm for 3min to enrich the activated bacteria solution, sucked off 900ul of the supernatant, mixed 100ul of the bacteria solution and spread it on an ampicillin-resistant culture dish, and cultured it upside down in a 37°C incubator overnight . Randomly select 10 single colonies for detection by PCR method, expand the positive clones in 6ml LB liquid medium, culture overnight at 37°C and 250rpm, collect the bacterial liquid and extract the plasmid. The obtained plasmid was sequenced and verified, and the sequencing results were consistent with expectations, and the Cas9 enzyme expression vector pTol2-HSP70-Cas9-2A-eGFP was obtained.
如图1所示,Cas9酶表达载体pTol2-HSP70-Cas9-2A-eGFP,包括:Cas9酶表达元件以及位于所述Cas9酶表达元件两端的转座子Tol2,所述Cas9酶表达元件包括热激诱导型启动子HSP70、和Cas9酶基因编码序列。As shown in Figure 1, the Cas9 enzyme expression vector pTol2-HSP70-Cas9-2A-eGFP includes: the Cas9 enzyme expression element and the transposon Tol2 positioned at both ends of the Cas9 enzyme expression element, and the Cas9 enzyme expression element includes heat shock Inducible promoter HSP70, and Cas9 enzyme gene coding sequence.
其中,热激诱导型启动子HSP70含有如SEQ ID NO.7所示的序列。如SEQ ID NO.7所示的序列具体详见序列表部分。Wherein, the heat shock inducible promoter HSP70 contains the sequence shown in SEQ ID NO.7. For the sequence shown in SEQ ID NO.7, please refer to the sequence listing section for details.
其中,Cas9酶基因编码序列含有如SEQ ID NO.8所示的序列。如SEQ ID NO.8所示的序列具体详见序列表部分。Wherein, the Cas9 enzyme gene coding sequence contains the sequence shown in SEQ ID NO.8. For the sequence shown in SEQ ID NO.8, please refer to the sequence listing section for details.
位于所述Cas9酶表达元件两端的转座子Tol2包括位于所述Cas9酶表达元件5’端的转座子Tol2和位于所述Cas9酶表达元件3’端的转座子Tol2。The transposon Tol2 located at both ends of the Cas9 enzyme expression element comprises the transposon Tol2 located at the 5' end of the Cas9 enzyme expression element and the transposon Tol2 located at the 3' end of the Cas9 enzyme expression element.
其中,位于所述Cas9酶表达元件5’端的转座子Tol2含有如SEQ ID NO.9所示的序列。如SEQ ID NO.9所示的序列具体详见序列表部分。Wherein, the transposon Tol2 located at the 5' end of the Cas9 enzyme expression element contains the sequence shown in SEQ ID NO.9. For the sequence shown in SEQ ID NO.9, please refer to the sequence listing section for details.
位于所述Cas9酶表达元件3’端的转座子Tol2含有如SEQ ID NO.10所示的序列。如SEQ ID NO.10所示的序列具体详见序列表部分。The transposon Tol2 located at the 3' end of the Cas9 enzyme expression element contains the sequence shown in SEQ ID NO.10. For the sequence shown in SEQ ID NO.10, please refer to the sequence listing section for details.
所述Cas9酶表达元件还包括荧光标记蛋白序列。所述荧光标记蛋白序列通过2A序列与Cas9酶基因编码序列连接。所述2A序列含有如SEQ ID NO.11所示的序列。如SEQ IDNO.11所示的序列具体详见序列表部分。The Cas9 enzyme expression element also includes a fluorescent marker protein sequence. The fluorescent marker protein sequence is connected with the coding sequence of the Cas9 enzyme gene through the 2A sequence. The 2A sequence contains the sequence shown in SEQ ID NO.11. For the sequence shown in SEQ ID NO.11, please refer to the sequence listing for details.
Cas9酶表达载体pTol2-HSP70-Cas9-2A-eGFP含有如SEQ ID NO.12所示的序列。如SEQ ID NO.12所示的序列具体详见序列表部分。The Cas9 enzyme expression vector pTol2-HSP70-Cas9-2A-eGFP contains the sequence shown in SEQ ID NO.12. For the sequence shown in SEQ ID NO.12, please refer to the sequence listing section for details.
实施例2将Cas9酶表达载体注射入斑马鱼受精卵Example 2 Injection of Cas9 enzyme expression vector into zebrafish fertilized eggs
(1)斑马鱼受精卵的获取(1) Obtaining zebrafish fertilized eggs
受精前将雌雄亲鱼分开按1:1-2比例放入产卵盒中进行隔离培养。产卵盒置于26℃-29℃恒温环境中进行黑暗过夜培养,光周期为白昼14h、黑暗10h。培养结束,抽离隔板并将底部有栅栏的内层倾斜放置在外层交配盒上,并放置在恒温环境中,得到斑马鱼受精卵。Before fertilization, the male and female broodstock were separated and placed in the spawning box at a ratio of 1:1-2 for isolation culture. The egg-laying box was placed in a constant temperature environment of 26°C-29°C for overnight culture in the dark, and the photoperiod was 14h in daylight and 10h in darkness. At the end of the cultivation, the partition board was removed and the inner layer with the fence at the bottom was obliquely placed on the outer layer mating box, and placed in a constant temperature environment to obtain fertilized zebrafish eggs.
(2)将Cas9酶表达载体注射入斑马鱼受精卵(2) Inject the Cas9 enzyme expression vector into zebrafish fertilized eggs
利用显微注射仪并参照显微注射法将实施例1构建好的Cas9酶表达载体pTol2-HSP70-Cas9-2A-eGFP(如图1所示)和Tol2mRNA共同注射入获得的斑马鱼单细胞受精卵。注射体系为10ul,其中Cas9表达载体50ng/ul,Tol2mRNA 1ul、酚红2ul,加水补足10ul。取0.6ul注射液注入毛细管中,将其装入注射仪中,按次序注射入斑马鱼受精卵的动物极。整个操作过程在45min内完成,以确保在细胞的第一次卵裂之前注射完成。Using a microinjector and referring to the microinjection method, the Cas9 enzyme expression vector pTol2-HSP70-Cas9-2A-eGFP constructed in Example 1 (as shown in Figure 1) and Tol2mRNA were co-injected into the obtained zebrafish single-cell fertilization egg. The injection system is 10ul, in which Cas9 expression vector is 50ng/ul, Tol2mRNA 1ul, phenol red 2ul, add water to make up 10ul. Take 0.6ul injection solution and inject it into the capillary, put it into the injector, and inject it into the animal poles of the zebrafish fertilized eggs in sequence. The entire operation process was completed within 45 minutes to ensure that the injection was completed before the first cleavage of the cells.
其中,所述Tol2mRNA含有如SEQ ID NO.13所示的序列。如SEQ ID NO.13所示的序列具体详见序列表部分。Wherein, the Tol2 mRNA contains the sequence shown in SEQ ID NO.13. For the sequence shown in SEQ ID NO.13, please refer to the sequence listing section for details.
(3)荧光筛选和子代培育(3) Fluorescence screening and offspring cultivation
注射后的受精卵培养于28℃,24h后在37℃恒温水浴锅孵育1h,然后利用体视显微镜进行观察,筛选带有绿色荧光的鱼卵进行孵育培养至成鱼。筛选后第1d-4d,所述斑马鱼胚胎在26℃-29℃恒温环境培育,获得幼鱼;第5d-9d幼鱼喂食卵黄水,每日喂食2次;第10d-16d,幼鱼2喂食丰年虫与滤网磨碎的卵黄水,具体方法是先向饲养容器中投入少量丰年虫,25min-35min后再加入滤网磨碎的卵黄水,每日喂食2次;第17d以后,幼鱼喂食丰年虫,每日喂食2次,每日更换一次养鱼水。After the injection, the fertilized eggs were cultured at 28°C, and after 24 hours, they were incubated in a constant temperature water bath at 37°C for 1 hour, then observed with a stereo microscope, and the eggs with green fluorescence were screened and incubated until they reached adult fish. On the 1d-4d after screening, the zebrafish embryos were cultivated in a constant temperature environment of 26°C-29°C to obtain juveniles; on the 5th-9d, the juveniles were fed with yolk water twice a day; Feed Artemia worms and yolk water ground with a filter. The specific method is to put a small amount of Artemia worms into the breeding container first, then add the yolk water ground with a filter after 25-35 minutes, and feed twice a day; after the 17th day, the young The fish were fed with Artemia, 2 times a day, and the fish water was changed once a day.
(4)筛选稳定遗传的纯系Cas9酶转基因斑马鱼(4) Screening of stable genetic pure line Cas9 enzyme transgenic zebrafish
首先剪取2月龄P0嵌合体个体尾鳍提取基因组DNA,PCR方法检测Cas9基因序列,PCR程序:94℃5min;94℃5s,55℃15s,72℃20s共35个循环,72℃5min。筛选PCR结果为阳性的P0斑马鱼与野生型斑马鱼进行杂交,将鱼卵置于37℃水浴锅孵育1h,然后在体视荧光显微镜下观察荧光,挑选出有绿色荧光的卵培育至性成熟,得到杂合体F1代。PCR检测F1代,筛选PCR结果为阳性的斑马鱼培育至性成熟,将此杂合体F1中的单个个体和野生型进行测交,二月龄后PCR筛选出阳性斑马鱼,培养至性成熟,此为杂合体F2。由于杂合体F2来源于同一亲本(杂合体F1和野生型),因此所有F2杂合子基因型一致。将杂合体F2中的雌鱼与雄鱼自交,其后代F3中,有1/4概率得到含Cas9转基因斑马鱼的纯合子F3。二月龄后PCR剪尾检测筛选所有的纯合子和杂合子,为验证其中的纯合子F3,将筛选出的F3继续与野生型测交并PCR检测F4鱼卵DNA,若F4鱼卵全部为PCR阳性,鱼卵37℃孵育后然后体视荧光显微镜观察全有绿色荧光,则可以确定其亲本F3为纯系。First, the caudal fin of the 2-month-old P0 chimera was cut to extract genomic DNA, and the Cas9 gene sequence was detected by PCR. The PCR program was: 94°C for 5 minutes; 94°C for 5s, 55°C for 15s, 72°C for 20s, and 72°C for 5 minutes. Screen the P0 zebrafish with positive PCR results and hybridize with the wild-type zebrafish, incubate the eggs in a 37°C water bath for 1 hour, then observe the fluorescence under a stereofluorescence microscope, and select eggs with green fluorescence to grow to sexual maturity , get the hybrid F1 generation. The F1 generation was detected by PCR, and the zebrafish with positive PCR results were selected and cultivated to sexual maturity, and a single individual in the hybrid F1 was tested with the wild type. After two months of age, positive zebrafish were screened by PCR and cultivated to sexual maturity. This is hybrid F2. Since the heterozygous F2 originates from the same parent (heterozygous F1 and wild type), all F2 heterozygotes have the same genotype. The female fish in the heterozygous F2 was selfed with the male fish, and among the offspring F3, there was a 1/4 probability of obtaining a homozygous F3 containing the Cas9 transgenic zebrafish. After two months of age, all homozygotes and heterozygotes were screened by PCR pruning detection. In order to verify the homozygous F3, the screened F3 was tested with the wild type and PCR was used to detect the F4 egg DNA. If all the F4 eggs were If the PCR is positive, and the fish eggs are incubated at 37°C and then observed with a stereoscopic fluorescence microscope, they all have green fluorescence, then it can be determined that the parent F3 is a pure line.
实施例3斑马鱼MC4R基因的敲除The knockout of embodiment 3 zebrafish MC4R gene
(1)MC4R基因打靶位点的确定和gRNA的制备(1) Determination of MC4R gene targeting sites and preparation of gRNA
设计MC4R基因打靶位点,根据网站(http://zifit.partners.org/favicon.ico)给出的结果选择合适的打靶序列,本发明选择的打靶序列如SEQ ID NO.1所示,具体为:GGGGGTGTTTGTGGTGTGCT。Design the MC4R gene targeting site, select the appropriate targeting sequence according to the results given by the website (http://zifit.partners.org/favicon.ico), the targeting sequence selected by the present invention is shown in SEQ ID NO.1, specifically For: GGGGGTGTTTGTGGTGTGCT.
本发明采用PCR的方法扩增出gRNA的转录模板。首先根据选定的打靶序列设计引物,上游引物序列如SEQ ID NO.2,具体为:The present invention adopts the method of PCR to amplify the transcription template of gRNA. First, design primers according to the selected targeting sequence, the upstream primer sequence is as SEQ ID NO.2, specifically:
TAATACGACTCACTATAGGGGGTGTTTGTGGTGTGCTGTTTTAGAGCTAGAAATAGC;下游引物序列如SEQ ID NO.3所示,具体为:AGCACCGACTCGGTGCCAC。TAATACGACTCACTATAGGGGGTGTTTGTGGTGTGCTGTTTTAGGCTAGAAATAGC; the downstream primer sequence is shown in SEQ ID NO.3, specifically: AGCACCGACTCGGTGCCAC.
以含有gRNA骨架的质粒为模板,骨架序列如SEQ ID NO.4所示,具体为:AGCTTGAAATTAATACGACTCACTATAGGGAGTCTTCAGATCTAACACACAACTCGAGGAAGACATGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTC GGTGCG。The plasmid containing the gRNA backbone is used as a template, and the backbone sequence is shown in SEQ ID NO.4, specifically: AGCTTGAAATTAATACGACTCACTATAGGGAGTCTTCAGATCTAACACAACTCGAGGAAGACATGTTTTGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAGTGGCACCGAGTC GGTGCG.
PCR扩增程序为:98℃5min;98℃10s,58℃30s,72℃20s共35个循环,72℃5min。PCR产物经1%琼脂糖凝胶电泳检测后,通过PCR产物纯化试剂盒回收产物。以纯化后的产物为模板进行体外转录,转录体系为20ul,其中纯化后的产物600ng,T7转录酶1ul,反应缓冲液2ul,dNTP混合物1ul,加无菌水补足20ul。37℃孵育3h。转录产物经1%琼脂糖凝胶电泳检测后,通过RNA纯化试剂盒纯化回收,获得gRNA,在-80℃冰箱保存。The PCR amplification program was: 98°C for 5min; 98°C for 10s, 58°C for 30s, 72°C for 20s, a total of 35 cycles, and 72°C for 5min. After the PCR product was detected by 1% agarose gel electrophoresis, the product was recovered by a PCR product purification kit. The purified product was used as a template for in vitro transcription. The transcription system was 20ul, including 600ng of purified product, 1ul of T7 transcriptase, 2ul of reaction buffer, 1ul of dNTP mixture, and 20ul of sterile water. Incubate at 37°C for 3h. After the transcript was detected by 1% agarose gel electrophoresis, it was purified and recovered by an RNA purification kit to obtain gRNA, which was stored in a -80°C refrigerator.
(2)体外显微注射与敲除验证(2) In vitro microinjection and knockout verification
准备受精卵:挑选性成熟的稳定遗传的纯系Cas9转基因斑马鱼(详见实施例2),2条雌鱼1条雄鱼,放入产卵盒,中间插入透明隔板将雌雄鱼分开。将产卵盒置于26℃-29℃恒温室中黑暗过夜饲养,光周期为白昼14h,黑暗10h。显微注射。次日上午,拔开透明隔板,保持安静的环境,让雌雄鱼自行追逐产卵。产卵后,立即收取受精卵,通过显微注射仪进行注射。注射体系为:gRNA 30ng/ul,酚红0.5ul,无菌水补足10ul。注射部位为受精卵的动物极,整个操作过程在45min内完成,以确保在细胞的第一次卵裂之前注射完成。敲除验证。注射后的受精卵在28℃培养。24h后,对照组取10颗,两个实验组每组取10颗斑马鱼受精卵,分别提取DNA,在gRNA打靶位点两侧选择500bp左右的序列设计引物,引物序列如SEQ ID NO.5和SEQ ID NO.6所示,Prepare fertilized eggs: select sexually mature and stable genetic pure-line Cas9 transgenic zebrafish (see Example 2 for details), 2 female fish and 1 male fish, put them into the spawning box, and insert a transparent partition in the middle to separate the male and female fish. Place the egg-laying box in a constant temperature room at 26°C-29°C for overnight rearing in the dark, with a photoperiod of 14 hours in the daytime and 10 hours in the dark. Microinjection. In the morning of the next day, pull out the transparent partition, keep a quiet environment, and let the male and female fish chase and lay eggs by themselves. Immediately after spawning, the fertilized eggs were collected and injected with a microinjector. The injection system is: gRNA 30ng/ul, phenol red 0.5ul, sterile water to supplement 10ul. The injection site is the animal pole of the fertilized egg, and the whole operation process is completed within 45 minutes to ensure that the injection is completed before the first cleavage of the cells. Knockout validation. The injected zygotes were cultured at 28°C. After 24 hours, take 10 fertilized zebrafish eggs from the control group and 10 fertilized zebrafish eggs from each of the two experimental groups, extract DNA respectively, and design primers with a sequence of about 500 bp on both sides of the gRNA targeting site. The primer sequence is as shown in SEQ ID NO.5 and shown in SEQ ID NO.6,
SEQ ID NO.5:GACCGCTACATCACAATCT;SEQ ID NO.5: GACCGCTACATCACAATCT;
SEQ ID NO.6:TTGGCTTCTGAAGGCATAT。SEQ ID NO. 6: TTGGCTTCTGAAGGCATAT.
以此引物对斑马鱼DNA进行扩增,98℃5min;98℃10s,52℃20s,72℃20s共35个循环,72℃5min。T7核酸内切酶I(T7E1)具有识别并切割不完全配对DNA、异源双链DNA特性,因此用该酶进行突变验证,反应体系为:PCR产物8.5ul,缓冲液1ul,混合均匀后,PCR仪中退火。退火程序为:95℃5min,94℃2sec,-0.1℃/cycle,200times,75℃1sec,-0.1℃/cycle,600times,16℃2min。退火完成后,加入0.5ulT7E1酶,37℃孵育30min。孵育完成后通过2%琼脂糖凝胶电泳检测是否敲除成功,结果如图5所示。随后亚克隆到测序载体中送样测序并同野生型基因序列进行比较验证,确认靶基因的有效敲除。剪尾检测成功的鱼(F0)与野生型杂交,得到F1代杂合体,通过测序与野生型比较,分别得到缺失5个、12个和8个碱基的基因型,引起基因的移码突变。结果如图4所示。Zebrafish DNA was amplified with these primers, 98°C for 5min; 98°C for 10s, 52°C for 20s, 72°C for 20s, a total of 35 cycles, 72°C for 5min. T7 endonuclease I (T7E1) has the characteristics of recognizing and cutting incompletely paired DNA and heteroduplex DNA, so this enzyme is used for mutation verification. The reaction system is: PCR product 8.5ul, buffer 1ul, after mixing evenly, Annealed in a PCR machine. The annealing program is: 95°C for 5min, 94°C for 2sec, -0.1°C/cycle, 200times, 75°C for 1sec, -0.1°C/cycle, 600times, 16°C for 2min. After the annealing is completed, add 0.5ul T7E1 enzyme and incubate at 37°C for 30min. After the incubation was completed, 2% agarose gel electrophoresis was used to detect whether the knockout was successful, and the results are shown in FIG. 5 . Then subcloned into the sequencing vector, sent for sequencing and compared with the wild-type gene sequence to confirm the effective knockout of the target gene. The fish (F0) with successful tail-cut detection were crossed with the wild type to obtain the F1 generation heterozygote, and compared with the wild type by sequencing, the genotypes with 5, 12 and 8 bases missing were respectively obtained, which caused the frameshift mutation of the gene . The result is shown in Figure 4.
Cas9转基因斑马鱼能实现对MC4R基因的有效敲除,说明Cas9转基因斑马鱼构建成功。与现代技术相比,本发明的有益效果是:(1)方法实施过程简单易控;(2)方法能获得Cas9转基因斑马鱼;(3)所得斑马鱼品系能为基因的敲除提供方便;(4)实现了对MC4R基因的有效敲除。The Cas9 transgenic zebrafish can effectively knock out the MC4R gene, indicating that the Cas9 transgenic zebrafish was successfully constructed. Compared with modern technology, the beneficial effects of the present invention are: (1) the implementation process of the method is simple and easy to control; (2) the method can obtain Cas9 transgenic zebrafish; (3) the obtained zebrafish strain can provide convenience for gene knockout; (4) Effective knockout of the MC4R gene was achieved.
以上所述,仅为本发明的较佳实施例,并非对本发明任何形式上和实质上的限制,应当指出,对于本技术领域的普通技术人员,在不脱离本发明方法的前提下,还将可以做出若干改进和补充,这些改进和补充也应视为本发明的保护范围。凡熟悉本专业的技术人员,在不脱离本发明的精神和范围的情况下,当可利用以上所揭示的技术内容而做出的些许更动、修饰与演变的等同变化,均为本发明的等效实施例;同时,凡依据本发明的实质技术对上述实施例所作的任何等同变化的更动、修饰与演变,均仍属于本发明的技术方案的范围内。The above description is only a preferred embodiment of the present invention, and is not intended to limit the present invention in any form and in essence. Several improvements and supplements can be made, and these improvements and supplements should also be regarded as the protection scope of the present invention. Those who are familiar with this profession, without departing from the spirit and scope of the present invention, when they can use the technical content disclosed above to make some changes, modifications and equivalent changes of evolution, are all included in the present invention. Equivalent embodiments; at the same time, all changes, modifications and evolutions of any equivalent changes made to the above-mentioned embodiments according to the substantive technology of the present invention still belong to the scope of the technical solution of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610614071.XA CN106434748A (en) | 2016-07-29 | 2016-07-29 | Development and applications of heat shock induced Cas9 enzyme transgene danio rerio |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610614071.XA CN106434748A (en) | 2016-07-29 | 2016-07-29 | Development and applications of heat shock induced Cas9 enzyme transgene danio rerio |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106434748A true CN106434748A (en) | 2017-02-22 |
Family
ID=58184745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610614071.XA Pending CN106434748A (en) | 2016-07-29 | 2016-07-29 | Development and applications of heat shock induced Cas9 enzyme transgene danio rerio |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106434748A (en) |
Cited By (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107043782A (en) * | 2017-04-10 | 2017-08-15 | 西南大学 | A kind of gene knockout method and its sgRNA fragments and application |
| US9999671B2 (en) | 2013-09-06 | 2018-06-19 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
| CN108192927A (en) * | 2017-12-29 | 2018-06-22 | 上海海洋大学 | A kind of gene editing of Oujiang Color Common Carp, Cyprinus carpio var. color is with being overexpressed operating method |
| CN108251452A (en) * | 2018-01-17 | 2018-07-06 | 扬州大学 | A kind of transgenic zebrafish for expressing Cas9 genes and its construction method and application |
| CN108531510A (en) * | 2018-05-16 | 2018-09-14 | 华南理工大学 | A kind of application of transgenic zebrafish in the animal model for preparing chronic myelocytic leukemia |
| US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
| US10113163B2 (en) | 2016-08-03 | 2018-10-30 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
| CN108929879A (en) * | 2017-05-24 | 2018-12-04 | 南方医科大学 | A kind of bacterial-infection resisting fish models and its preparation method and application |
| US10167457B2 (en) | 2015-10-23 | 2019-01-01 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US10465176B2 (en) | 2013-12-12 | 2019-11-05 | President And Fellows Of Harvard College | Cas variants for gene editing |
| US10508298B2 (en) | 2013-08-09 | 2019-12-17 | President And Fellows Of Harvard College | Methods for identifying a target site of a CAS9 nuclease |
| CN110747186A (en) * | 2019-11-07 | 2020-02-04 | 北京大学 | CRISPR/Cas9 systems and methods for efficient generation of mutants that do not carry transgenic elements in plants |
| US10597679B2 (en) | 2013-09-06 | 2020-03-24 | President And Fellows Of Harvard College | Switchable Cas9 nucleases and uses thereof |
| CN111149730A (en) * | 2019-12-25 | 2020-05-15 | 湖南师范大学 | Method for rapidly cultivating homozygous individuals of pluripotent stem cell fluorescence-labeled zebra fish |
| CN111386038A (en) * | 2017-09-28 | 2020-07-07 | 国立大学法人京都大学 | Fish and production method thereof |
| US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
| US10858639B2 (en) | 2013-09-06 | 2020-12-08 | President And Fellows Of Harvard College | CAS9 variants and uses thereof |
| CN112955540A (en) * | 2018-08-30 | 2021-06-11 | 因思科瑞普特公司 | Improved detection of nuclease edited sequences in automated modules and instruments |
| US11046948B2 (en) | 2013-08-22 | 2021-06-29 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US11268082B2 (en) | 2017-03-23 | 2022-03-08 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
| US11306324B2 (en) | 2016-10-14 | 2022-04-19 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
| US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
| US11447770B1 (en) | 2019-03-19 | 2022-09-20 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
| US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
| US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
| US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| US11912985B2 (en) | 2020-05-08 | 2024-02-27 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
| US12281338B2 (en) | 2018-10-29 | 2025-04-22 | The Broad Institute, Inc. | Nucleobase editors comprising GeoCas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| US12390514B2 (en) | 2017-03-09 | 2025-08-19 | President And Fellows Of Harvard College | Cancer vaccine |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105274141A (en) * | 2015-11-20 | 2016-01-27 | 中国科学院水生生物研究所 | Transgenic vector for target mutation of primordial germ cells, method for preparing transgenic vector and application thereof |
-
2016
- 2016-07-29 CN CN201610614071.XA patent/CN106434748A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105274141A (en) * | 2015-11-20 | 2016-01-27 | 中国科学院水生生物研究所 | Transgenic vector for target mutation of primordial germ cells, method for preparing transgenic vector and application thereof |
Non-Patent Citations (4)
| Title |
|---|
| JULIEN ABLAIN等: "A CRISPR Cas9 Vector System for Tissue-Specific Gene Disruption in Zebrafish", 《DEVELOPMENTAL CELL》 * |
| YUKIKO KIMURA等: "Efficient generation of knock-in transgenic zebrafish carrying reporter driver genes by CRISPR Cas9-mediated genome engineering", 《SCIENTIFIC REPORTS》 * |
| 刘勇等: "GAL4/fUAS系统在果蝇Tis11基因RNA干扰中的应用", 《生命科学研究》 * |
| 杜久林等: "CRISPR/Cas9技术在斑马鱼基因修饰中的应用", 《生命科学》 * |
Cited By (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12006520B2 (en) | 2011-07-22 | 2024-06-11 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US11920181B2 (en) | 2013-08-09 | 2024-03-05 | President And Fellows Of Harvard College | Nuclease profiling system |
| US10508298B2 (en) | 2013-08-09 | 2019-12-17 | President And Fellows Of Harvard College | Methods for identifying a target site of a CAS9 nuclease |
| US10954548B2 (en) | 2013-08-09 | 2021-03-23 | President And Fellows Of Harvard College | Nuclease profiling system |
| US11046948B2 (en) | 2013-08-22 | 2021-06-29 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US11299755B2 (en) | 2013-09-06 | 2022-04-12 | President And Fellows Of Harvard College | Switchable CAS9 nucleases and uses thereof |
| US10858639B2 (en) | 2013-09-06 | 2020-12-08 | President And Fellows Of Harvard College | CAS9 variants and uses thereof |
| US10912833B2 (en) | 2013-09-06 | 2021-02-09 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
| US10597679B2 (en) | 2013-09-06 | 2020-03-24 | President And Fellows Of Harvard College | Switchable Cas9 nucleases and uses thereof |
| US10682410B2 (en) | 2013-09-06 | 2020-06-16 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US12473573B2 (en) | 2013-09-06 | 2025-11-18 | President And Fellows Of Harvard College | Switchable Cas9 nucleases and uses thereof |
| US9999671B2 (en) | 2013-09-06 | 2018-06-19 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
| US12215365B2 (en) | 2013-12-12 | 2025-02-04 | President And Fellows Of Harvard College | Cas variants for gene editing |
| US11053481B2 (en) | 2013-12-12 | 2021-07-06 | President And Fellows Of Harvard College | Fusions of Cas9 domains and nucleic acid-editing domains |
| US10465176B2 (en) | 2013-12-12 | 2019-11-05 | President And Fellows Of Harvard College | Cas variants for gene editing |
| US11124782B2 (en) | 2013-12-12 | 2021-09-21 | President And Fellows Of Harvard College | Cas variants for gene editing |
| US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
| US10704062B2 (en) | 2014-07-30 | 2020-07-07 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
| US11578343B2 (en) | 2014-07-30 | 2023-02-14 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
| US12398406B2 (en) | 2014-07-30 | 2025-08-26 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
| US10167457B2 (en) | 2015-10-23 | 2019-01-01 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| US11214780B2 (en) | 2015-10-23 | 2022-01-04 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| US12043852B2 (en) | 2015-10-23 | 2024-07-23 | President And Fellows Of Harvard College | Evolved Cas9 proteins for gene editing |
| US12344869B2 (en) | 2015-10-23 | 2025-07-01 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| US10113163B2 (en) | 2016-08-03 | 2018-10-30 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
| US10947530B2 (en) | 2016-08-03 | 2021-03-16 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
| US11702651B2 (en) | 2016-08-03 | 2023-07-18 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
| US11999947B2 (en) | 2016-08-03 | 2024-06-04 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| US12084663B2 (en) | 2016-08-24 | 2024-09-10 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| US11306324B2 (en) | 2016-10-14 | 2022-04-19 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
| US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
| US11820969B2 (en) | 2016-12-23 | 2023-11-21 | President And Fellows Of Harvard College | Editing of CCR2 receptor gene to protect against HIV infection |
| US12516308B2 (en) | 2017-03-09 | 2026-01-06 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| US12390514B2 (en) | 2017-03-09 | 2025-08-19 | President And Fellows Of Harvard College | Cancer vaccine |
| US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
| US12435331B2 (en) | 2017-03-10 | 2025-10-07 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
| US11268082B2 (en) | 2017-03-23 | 2022-03-08 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
| CN107043782A (en) * | 2017-04-10 | 2017-08-15 | 西南大学 | A kind of gene knockout method and its sgRNA fragments and application |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| CN108929879B (en) * | 2017-05-24 | 2021-08-20 | 南方医科大学 | A kind of anti-bacterial infection fish model and its preparation method and use |
| CN108929879A (en) * | 2017-05-24 | 2018-12-04 | 南方医科大学 | A kind of bacterial-infection resisting fish models and its preparation method and application |
| US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
| US12359218B2 (en) | 2017-07-28 | 2025-07-15 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
| US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
| US11932884B2 (en) | 2017-08-30 | 2024-03-19 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
| CN111386038A (en) * | 2017-09-28 | 2020-07-07 | 国立大学法人京都大学 | Fish and production method thereof |
| US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| CN108192927A (en) * | 2017-12-29 | 2018-06-22 | 上海海洋大学 | A kind of gene editing of Oujiang Color Common Carp, Cyprinus carpio var. color is with being overexpressed operating method |
| CN108251452A (en) * | 2018-01-17 | 2018-07-06 | 扬州大学 | A kind of transgenic zebrafish for expressing Cas9 genes and its construction method and application |
| CN108531510A (en) * | 2018-05-16 | 2018-09-14 | 华南理工大学 | A kind of application of transgenic zebrafish in the animal model for preparing chronic myelocytic leukemia |
| US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
| CN112955540A (en) * | 2018-08-30 | 2021-06-11 | 因思科瑞普特公司 | Improved detection of nuclease edited sequences in automated modules and instruments |
| US12281338B2 (en) | 2018-10-29 | 2025-04-22 | The Broad Institute, Inc. | Nucleobase editors comprising GeoCas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| US12281303B2 (en) | 2019-03-19 | 2025-04-22 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
| US11447770B1 (en) | 2019-03-19 | 2022-09-20 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
| US12509680B2 (en) | 2019-03-19 | 2025-12-30 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
| US11643652B2 (en) | 2019-03-19 | 2023-05-09 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
| US11795452B2 (en) | 2019-03-19 | 2023-10-24 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| CN110747186B (en) * | 2019-11-07 | 2021-07-30 | 北京大学 | CRISPR/Cas9 systems and methods for efficient generation of mutants that do not carry transgenic elements in plants |
| CN110747186A (en) * | 2019-11-07 | 2020-02-04 | 北京大学 | CRISPR/Cas9 systems and methods for efficient generation of mutants that do not carry transgenic elements in plants |
| CN111149730B (en) * | 2019-12-25 | 2021-04-13 | 湖南师范大学 | A method for rapid cultivation of pluripotent stem cells fluorescently labeled zebrafish homozygous individuals |
| CN111149730A (en) * | 2019-12-25 | 2020-05-15 | 湖南师范大学 | Method for rapidly cultivating homozygous individuals of pluripotent stem cell fluorescence-labeled zebra fish |
| US11912985B2 (en) | 2020-05-08 | 2024-02-27 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| US12031126B2 (en) | 2020-05-08 | 2024-07-09 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106434748A (en) | Development and applications of heat shock induced Cas9 enzyme transgene danio rerio | |
| CN106191114B (en) | Breeding method for knocking out fish MC4R gene by using CRISPR-Cas9 system | |
| CN106047930B (en) | Preparation method of Flox rat with conditional knockout of PS1 gene | |
| CN104195177B (en) | A kind of method for significantly improving Fish genomes editorial efficiency | |
| CN108148873A (en) | A kind of CAV-1 gene delections zebra fish and preparation method thereof | |
| US9187764B2 (en) | Controllable on-off method for fish reproduction | |
| CN102653756B (en) | Directional modification method of specific gene of animal genome and application thereof | |
| CN112226465B (en) | Application of isolated nucleotide sequence in construction of mineralizeless intermuscular bone zebra fish | |
| CN110643636B (en) | A kind of method and application of knocking out MSTNa&b gene of bream | |
| CN105274140A (en) | Method for building muscle cell-specific expression mCherry fluorescent protein zebra fish family | |
| CN114438132A (en) | A method for establishing a homozygous knockout line of nile tilapia mstnb and the fast-growing line obtained therefrom | |
| CN106480093A (en) | Oocyte expresses mCherry albumen Brachydanio rerio family construction method | |
| CN108103108A (en) | Preparation and application of Cebpa gene-deleted zebra fish mutant | |
| CN114231561A (en) | A method for knocking down animal mRNA based on CRISPR-Cas13d and its application | |
| CN114934124A (en) | Method for breeding hexagrammos otakii with rapid growth potential | |
| CN118525810B (en) | A method for creating polyploid fish by knocking out the spo11 gene | |
| CN108715862A (en) | The preparation method of ddx19 gene delection zebra fish mutant | |
| CN110157744A (en) | A honeybee CRISPR-Cas9 gene editing method | |
| CN110592122B (en) | Zebra fish naalad2 gene promoter and application thereof | |
| CN116904523A (en) | Method for constructing female tilapia with egg laying behavior deletion by using gene editing technology | |
| CN105063088B (en) | A kind of method of production of ecological safety type fluorescent transgenic ornamental fish | |
| CN110643605B (en) | A gRNA and its template for Knockout MSTNa&b gene in bream | |
| KR101255197B1 (en) | Double transgenic sterile fluorescent marine medaka | |
| CN109355313A (en) | A kind of seed production method of Oujiang color carp lacking dorsal fin | |
| TWI464264B (en) | Production method of transgenic goldfish and gene expression vector for the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170222 |